CISCRP Launches Clinical Trial Volunteer Awareness and Recognition Campaign in USA Today

Share Article

The Center for Information and Study on Clinical Research Participation (CISCRP) launches a national clinical trial outreach and awareness initiative in USA Today to educate and inform the public and patients about the clinical research process.

The Clinical Trials supplement features educational articles and inspiring stories about clinical research for patients and the public.

It is only in collaboration with patients that we can advance medical innovation and truly improve the health of people around the world.

The nonprofit Center for Information and Study on Clinical Research Participation (CISCRP) announces that it is launching a new campaign, The National Clinical Trial Outreach and Awareness Initiative, to reach millions of Americans. Several times each year - beginning with USA Today on May 12th - CISCRP will be producing and distributing educational supplements in major national newspapers designed to inform the public and patients about the clinical research process.

Each supplement will include educational feature articles and messages about the important role that clinical research volunteers play in advancing public health. In this first edition on Clinical Trials, CISCRP has teamed up with several leading organizations including TransCelerate Biopharma Inc., Biogen, Merck, Pfizer Inc., Janssen Pharmaceuticals Inc., Segal Institute for Clinical Research, and Praxis to develop the educational and laudatory materials. The USA Today supplement hit newsstands in a number of major cities including Boston, New York, Phoenix, Washington D.C., Baltimore, and Los Angeles.

Although an estimated 75,000 clinical trials are conducted each year for severe and debilitating disease conditions, the majority of the public and patients report knowing very little about clinical research and where to go to learn more. CISCRP is launching The National Clinical Trial Outreach and Awareness Initiative to raise the visibility of clinical research, to provide general education, and to elevate the level of public and patient preparedness to navigate the clinical research process. The current supplement is expected to reach more than 20 million people through print and digital channels.

“Clinical trials are the life blood of scientific invention, and the generosity of study volunteers is essential as we work together toward medical breakthroughs that can have a lasting impact on people’s health, well-being, and welfare,” said Andy Lee, Senior Vice President of Global Clinical Trial Operations at Merck Research Laboratories. “Merck salutes the patient volunteers who are helping to push the boundaries of science, and helping ensure better health for society today and for generations to come.”

Recognizing those study volunteers who do participate in clinical trials is essential to spreading awareness about the important role that they play in the clinical research process and in improving public health. Murray Abramson, Vice President of Global Clinical Operations at Biogen, comments “Without patients' contributions and voice, solving the greatest challenges in medicine and conquering disease would not be possible. Patients, thank you!!!”

Content in this USA Today Supplement on Clinical Trials includes an advertisement thanking and honoring individuals who have given the gift of their participation in clinical trials; a feature story about one young women’s experience in clinical trials; and a headline profile about T.J. Sharpe, a melanoma cancer survivor and clinical trial participant.

Dalvir Gill, PhD, CEO of TransCelerate BioPharma, Inc., noted, “Enhancing the patient experience as they move through their clinical research journey is of utmost importance. That includes facilitating their ability to find and enroll in trials, and supporting their understanding of how a clinical trial works. It also means that the broader industry needs to continue to drive the advancement of innovative solutions that will ease patient burden, and identify efficiencies to make recruitment and participation in clinical research easier. It is only in collaboration with patients that we can advance medical innovation and truly improve the health of people around the world.”

The clinical trials supplement is available on newsstands on May 12th. To view the digital supplement, visit CISCRP’s website.

Be sure to check the CISCRP website frequently for more information on upcoming outreach and awareness campaigns and how you can get involved.

ABOUT CISCRP:
The Center for Information and Study on Clinical Research Participation (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities. Visit http://www.CISCRP.org for more information or to support CISCRP’s educational initiatives.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rachel Minnick
CISCRP
+1 (617) 725-2750 Ext: 330
Email >
@CISCRP
Follow >
Visit website